Increased entropy of signal transduction in the cancer metastasis phenotype

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Teschendorff, Andrew E ^a   Severini, Simone ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN;

ARTICLE; BIOLOGY; BREAST TUMOR; COHORT ANALYSIS; DISEASE COURSE; ENTROPY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; GENOMICS; HUMAN; METABOLISM; METASTASIS; NEOPLASM; PATHOLOGY; PHENOTYPE; PROGNOSIS; REPRODUCIBILITY; SIGNAL TRANSDUCTION; STATISTICS;

BREAST NEOPLASMS; COHORT STUDIES; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; ENTROPY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; PHENOTYPE; PROGNOSIS; PROTEINS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STOCHASTIC PROCESSES;

EID: 77955062175     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-104     Document Type: Article

References (41)

1. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004, 5:101-113. 10.1038/nrg1272, 14735121.
2. Prasad TS, Kandasamy K, Pandey A. Human protein reference database and human proteinpedia as discovery tools for systems biology. Methods Mol Biol 2009, 577:67-79. full_text, 19718509.
3. Stelzl U, Wanker EE. The value of high quality protein-protein interaction networks for systems biology. Curr Opin Chem Biol 2006, 10:551-558. 10.1016/j.cbpa.2006.10.005, 17055769.
4. Brown KR, Jurisica I. Online predicted human interaction database. Bioinformatics 2005, 21:2076-2082. 10.1093/bioinformatics/bti273, 15657099.
5. Jeong H, Mason SP, Barabási AL, Oltvai ZN. Lethality and centrality in protein networks. Nature 2001, 411:41-42. 10.1038/35075138, 11333967.
6. Hornberg JJ, Bruggeman FJ, Westerhoff HV, Lankelma J. Cancer: a systems biology disease. Biosystems 2006, 83:81-90. 10.1016/j.biosystems.2005.05.014, 16426740.
7. Jonsson PF, Bates PA. Global topological features of cancer proteins in the human interactome. Bioinformatics 2006, 22:2291-2297. 10.1093/bioinformatics/btl390, 1865486, 16844706.
8. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, et al. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 2004, 430:88-93. 10.1038/nature02555, 15190252.
9. Yu H, Kim PM, Sprecher E, Trifonov V, Gerstein M. The importance of bottlenecks in protein networks: correlation with gene essentiality and expression dynamics. PLoS Comput Biol 2007, 3:e59. 10.1371/journal.pcbi.0030059, 1853125,1853125, 17447836.
10. Ozgür A, Vu T, Erkan G, Radev DR. Identifying gene-disease associations using centrality on a literature mined gene-interaction network. Bioinformatics 2008, 24:i277-i285. 10.1093/bioinformatics/btn182, 2718658, 18586725.
11. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol 2009, 27:199-204. 10.1038/nbt.1522, 19182785.
12. Platzer A, Perco P, Lukas A, Mayer B. Characterization of protein-interaction networks in tumors. BMC Bioinformatics 2007, 8:224. 10.1186/1471-2105-8-224, 1929125, 17597514.
13. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol 2007, 3:140. 10.1038/msb4100180, 2063581, 17940530.
14. Rapaport F, Zinovyev A, Dutreix M, Barillot E, Vert JP. Classification of microarray data using gene networks. BMC Bioinformatics 2007, 8:35. 10.1186/1471-2105-8-35, 1797191, 17270037.
15. Ulitsky I, Shamir R. Identification of functional modules using network topology and high-throughput data. BMC Syst Biol 2007, 1:8. 10.1186/1752-0509-1-8, 1839897, 17408515.
16. Schäfer J, Strimmer K. An empirical bayes approach to inferring large-scale gene association networks. Bioinformatics 2005, 21:754-764. 10.1093/bioinformatics/bti062, 15479708.
17. Tuck DP, Kluger HM, Kluger Y. Characterizing disease states from topological properties of transcriptional regulatory networks. BMC Bioinformatics 2006, 7:236. 10.1186/1471-2105-7-236, 1482723, 16670008.
18. Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, et al. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007, 39:1338-1349. 10.1038/ng.2007.2, 17922014.
19. Nibbe RK, Koyutürk M, Chance MR. An integrative -omics approach to identify functional subnetworks in human colorectal cancer. PLoS Comput Biol 2010, 6:e1000639. 10.1371/journal.pcbi.1000639, 2797084, 20090827.
20. Barrat A, Barthelemy M, Vespignani A. Dynamical Processes on Complex Networks. CUP 2008,
21. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006, 38:1043-1048. 10.1038/ng1861, 16921376.
22. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability--an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010, 11:220-228. 10.1038/nrm2858, 20177397.
23. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
24. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006, 10:529-541. 10.1016/j.ccr.2006.10.009, 17157792.
25. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, et al. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 2007, 25:1239-1246. 10.1200/JCO.2006.07.1522, 17401012.
26. Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res 2008, 68:5405-5413. 10.1158/0008-5472.CAN-07-5206, 18593943.
27. Derrida B, Flyvbjerg H. Statistical properties of randomly broken objects and of multivalley structures in disordered systems. J Phys A:Math Gen 1987, 20:5273-5288.
28. Barthelemy M, Gondran B, Guichard E. Spatial structure of internet traffic. Physica A 2003, 319:633-642.
29. Bates DM, Watts DG. Nonlinear Regression Analysis and Its Applications 1988, Wiley.
30. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003, 100:9440-9445. 10.1073/pnas.1530509100, 170937, 12883005.
31. Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, et al. High-resolution acgh and expression profiling identifies a novel genomic subtype of er negative breast cancer. Genome Biol 2007, 8:R215. 10.1186/gb-2007-8-10-r215, 2246289, 17925008.
32. Teschendorff AE, Naderi A, Barbosa-Morais NL, Caldas C. Pack: Profile analysis using clustering and kurtosis to find molecular classifiers in cancer. Bioinformatics 2006, 22:2269-2275. 10.1093/bioinformatics/btl174, 16682424.
33. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006, 98:262-272. 10.1093/jnci/djj052, 16478745.
34. Pardoll D. Metastasis-promoting immunity: when t cells turn to the dark side. Cancer Cell 2009, 16:81-82. 10.1016/j.ccr.2009.07.007, 19647215.
35. Teschendorff AE, Miremadi A, Pinder SE, Ellis IO, Caldas C. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer. Genome Biol 2007, 8:R157. 10.1186/gb-2007-8-8-r157, 2374988, 17683518.
36. Teschendorff AE, Caldas C. A robust classifier of high predictive value to identify good prognosis patients in er-negative breast cancer. Breast Cancer Res 2008, 10:R73. 10.1186/bcr2138, 2575547, 18755024.
37. Neuberg M, Buckbinder L, Seizinger B, Kley N. The p53/igf-1 receptor axis in the regulation of programmed cell death. Endocrine 1997, 7:107-109. 10.1007/BF02778075, 9449044.
38. Samani AA, Yakar S, LeRoith D, Brodt P. The role of the igf system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007, 28:20-47. 10.1210/er.2006-0001, 16931767.
39. Yee D, Wood TL. The igf system in mammary development and breast cancer. J Mammary Gland Biol Neoplasia 2008, 13:351-352. 10.1007/s10911-008-9096-2, 19030973.
40. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, et al. A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 2007, 26:1507-1516. 10.1038/sj.onc.1209920, 16936776.
41. Farmer P, Bonnefoi H, Anderle P, Cameron D, Wirapati P, et al. A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 2009, 15:68-74. 10.1038/nm.1908, 19122658.